342 related articles for article (PubMed ID: 36925687)
1. Phage engineering and phage-assisted CRISPR-Cas delivery to combat multidrug-resistant pathogens.
Khambhati K; Bhattacharjee G; Gohil N; Dhanoa GK; Sagona AP; Mani I; Bui NL; Chu DT; Karapurkar JK; Jang SH; Chung HY; Maurya R; Alzahrani KJ; Ramakrishna S; Singh V
Bioeng Transl Med; 2023 Mar; 8(2):e10381. PubMed ID: 36925687
[TBL] [Abstract][Full Text] [Related]
2. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens.
Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK
Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428
[TBL] [Abstract][Full Text] [Related]
3. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
Usman SS; Uba AI; Christina E
Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
[TBL] [Abstract][Full Text] [Related]
4. Phage-delivered sensitisation with subsequent antibiotic treatment reveals sustained effect against antimicrobial resistant bacteria.
Liu H; Li H; Liang Y; Du X; Yang C; Yang L; Xie J; Zhao R; Tong Y; Qiu S; Song H
Theranostics; 2020; 10(14):6310-6321. PubMed ID: 32483454
[TBL] [Abstract][Full Text] [Related]
5. Variability in the durability of CRISPR-Cas immunity.
Chabas H; Nicot A; Meaden S; Westra ER; Tremblay DM; Pradier L; Lion S; Moineau S; Gandon S
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180097. PubMed ID: 30905283
[TBL] [Abstract][Full Text] [Related]
6. Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria.
Yosef I; Manor M; Kiro R; Qimron U
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7267-72. PubMed ID: 26060300
[TBL] [Abstract][Full Text] [Related]
7. Approaches for bacteriophage genome engineering.
Mahler M; Costa AR; van Beljouw SPB; Fineran PC; Brouns SJJ
Trends Biotechnol; 2023 May; 41(5):669-685. PubMed ID: 36117025
[TBL] [Abstract][Full Text] [Related]
8. Evolutionary Dynamics between Phages and Bacteria as a Possible Approach for Designing Effective Phage Therapies against Antibiotic-Resistant Bacteria.
Hasan M; Ahn J
Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884169
[TBL] [Abstract][Full Text] [Related]
9. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
Shen J; Zhou J; Chen GQ; Xiu ZL
J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
[No Abstract] [Full Text] [Related]
10. Delivery of CRISPR-Cas systems using phage-based vectors.
Fage C; Lemire N; Moineau S
Curr Opin Biotechnol; 2021 Apr; 68():174-180. PubMed ID: 33360715
[TBL] [Abstract][Full Text] [Related]
11. Genetic engineering of a temperate phage-based delivery system for CRISPR/Cas9 antimicrobials against Staphylococcus aureus.
Park JY; Moon BY; Park JW; Thornton JA; Park YH; Seo KS
Sci Rep; 2017 Mar; 7():44929. PubMed ID: 28322317
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the CRISPR-Cas Systems to Combat Antimicrobial Resistance.
Duan C; Cao H; Zhang LH; Xu Z
Front Microbiol; 2021; 12():716064. PubMed ID: 34489905
[TBL] [Abstract][Full Text] [Related]
13. Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome.
Nath A; Bhattacharjee R; Nandi A; Sinha A; Kar S; Manoharan N; Mitra S; Mojumdar A; Panda PK; Patro S; Dutt A; Ahuja R; Verma SK; Suar M
Biomed Pharmacother; 2022 Jul; 151():113122. PubMed ID: 35594718
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas10 assisted editing of virulent staphylococcal phages.
Nayeemul Bari SM; Hatoum-Aslan A
Methods Enzymol; 2019; 616():385-409. PubMed ID: 30691652
[TBL] [Abstract][Full Text] [Related]
15. Bacterial genome engineering and synthetic biology: combating pathogens.
Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
[TBL] [Abstract][Full Text] [Related]
16. A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity.
Seed KD; Lazinski DW; Calderwood SB; Camilli A
Nature; 2013 Feb; 494(7438):489-91. PubMed ID: 23446421
[TBL] [Abstract][Full Text] [Related]
17. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.
Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA
mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642
[TBL] [Abstract][Full Text] [Related]
18. Broadscale phage therapy is unlikely to select for widespread evolution of bacterial resistance to virus infection.
Cohan FM; Zandi M; Turner PE
Virus Evol; 2020 Jul; 6(2):veaa060. PubMed ID: 33365149
[TBL] [Abstract][Full Text] [Related]
19. Genetic and Chemical Engineering of Phages for Controlling Multidrug-Resistant Bacteria.
Guo D; Chen J; Zhao X; Luo Y; Jin M; Fan F; Park C; Yang X; Sun C; Yan J; Chen W; Liu Z
Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33669513
[TBL] [Abstract][Full Text] [Related]
20. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
